GKOS Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Shares TLSI Q1 2026 Earnings EPS Surprises Positively Despite No Revenue Stock Declines YDKG Q4 2012 Earnings EPS Misses Estimates as Stock Rises on Strategic Progress Castle Biosciences Q1 2026 Earnings NarrowerThanExpected Loss Stock Slips BWNB Q1 2026 Earnings Significant EPS Miss Highlights Persistent Cost Pressures Seadrill SDRL Slips 13 as Offshore Drilling Stock Tests Key Support Levels Skye Bioscience SKYE Edges Higher as Support Holds Testing Key Resistance at 088 Vera Therapeutics VERA Edges Higher Testing Resistance Amid Steady Volume Mixed Martial Arts Group MMA Makes a Move Testing Key Resistance at 060 BNR Q3 2022 Earnings Narrower Loss Surpasses Estimates Stock Declines